Pharmabiz4h
NRx Pharma announces 12-month real-time stability on first manufactured commercial scale lot of NRX-100
NRx Pharma announces 12-month real-time stability on first manufactured commercial scale lot of NRX-100: Radnor, Pennsylvania Thursday, October 3, 2024, 17:00 Hrs [IST] NRx Pharma ...
Pharmabiz4h
KIMS inks MoU with Intuitive to launch 25 new robotic surgery programmes; Expanding accessibility in tier 2 & 3 cities
KIMS inks MoU with Intuitive to launch 25 new robotic surgery programmes; Expanding accessibility in tier 2 & 3 cities ...
Pharmabiz4h
Dr Reddy’s inks voluntary licensing pact with Gilead to manufacture and commercialise lenacapavir in India and other countries
Dr Reddy’s inks voluntary licensing pact with Gilead to manufacture and commercialise lenacapavir in India and other countries: Our Bureau, Bengaluru Thursday, October 3, 2024, ...
Pharmabiz3h
Santhera reports positive results from LIONHEART study with Agamree demonstrating unique mineralocorticoid receptor antagonism
Santhera reports positive results from LIONHEART study with Agamree demonstrating unique mineralocorticoid receptor antagonism: Pratteln, Switzerland Thursday, October 3, 2024, 18 ...
Pharmabiz6h
Sapience Therapeutics begins patient enrolment in phase 2 study of first-in-class ß-catenin antagonist, ST316 in colorectal cancer
Tarrytown, New York Thursday, October 3, 2024, 15:00 Hrs [IST] ...
Pharmabiz5h
CDSCO becomes affiliated member of IMDRF
The Central Drugs Standard Control Organization (CDSCO) has received approval from International Medical Device Regulators Forum (IMDRF) as an affiliate member of the Forum. The ministry of health and ...
Pharmabiz7h
Qiagen introduces QIAcuityDx digital PCR system for clinical testing in oncology
Qiagen introduces QIAcuityDx digital PCR system for clinical testing in oncology: Venlo, the Netherlands Thursday, October 3, 2024, 14:00 Hrs [IST] Qiagen N.V., a Netherlands-base ...
Pharmabiz8h
Biocon Biologics refinances US$ 1.1 billion long term debt through US$ bonds and new syndicated facility
Biocon Biologics refinances US$ 1.1 billion long term debt through US$ bonds and new syndicated facility: Our Bureau, Bengaluru Thursday, October 3, 2024, 12:30 Hrs [IST] Biocon B ...
Pharmabiz9h
Gilead Sciences signs voluntary licensing agreement with six pharma firms to produce generic lenacapavir
Gilead Sciences signs voluntary licensing agreement with six pharma firms to produce generic lenacapavir: Our Bureau, New Delhi Thursday, October 3, 2024, 11:30 Hrs [IST] US-based ...
Pharmabiz11h
Merck completes acquisition of investigational B-cell depletion therapy, CN201 from Curon Biopharma
Merck completes acquisition of investigational B-cell depletion therapy, CN201 from Curon Biopharma: Rahway, New Jersey Thursday, October 3, 2024, 10:00 Hrs [IST] Merck, known as ...
Pharmabiz10h
Eppendorf introduces CO2 incubator shaker, CellXpert CS220 on the market with integrated 180°C sterilization routine
Eppendorf introduces CO2 incubator shaker, CellXpert CS220 on the market with integrated 180°C sterilization routine: Hamburg, Germany Thursday, October 3, 2024, 11:00 Hrs [IST] ...
Pharmabiz13h
A STEP IN RIGHT DIRECTION TO DIE WITH DIGNITY
Upholding a citizen's right to die with dignity, the apex court had allowed a person to draft a living will specifying that he or she should not be put on life support system if they slip into a ...